Detailed Result for NCT03135249
NCT ID: | NCT03135249 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2017-04-12 |
Last Update Submitted Date: | 2022-01-24 |
Last Update Submitted Date: | 2022-01-24 |
Result First Submitted Date: | 2021-09-02 |
Disposition First Submitted Date: | N/A |
Start Month Year: | May 1, 2018 |
Start Date: | 2018-05-01 |
Start Date Type: | Actual |
Verification Month Year: | January 2022 |
Verification Date: | 2022-01-31 |
Completion Month Year: | November 4, 2020 |
Completion Date: | 2020-11-04 |
Completion Date Type: | Actual |
Primary Completion Month Year: | November 4, 2020 |
Primary Completion Date: | 2020-11-04 |
Primary Completion Date Type: | Actual |
Study first Submitted QC Date: | 2017-04-25 |
Study first posted Date: | 2017-05-01 |
Result first Submitted QC Date: | 2022-01-24 |
Result First Posted Date: | 2022-02-15 |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2022-01-24 |
Last Updated Posted Date: | 2022-02-15 |
Target Duration: | N/A |
Study Type: | Interventional |
Acronym: | SUPPRESS |
Baseline Population: | N/A |
Brief Title: | Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis |
Official Title: | Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis (SUPPRESS) |
Overall Status: | Completed |
Last Known Status: | N/A |
Phase: | Phase 4 |
Enrollment: | 9 |
Enrollment Type: | Actual |
Source: | University of Texas Southwestern Medical Center |
Limitation and Caveats: | N/A |
Number of Arms: | 1 |
Number of Groups: | N/A |
Why Stopped: | N/A |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | true |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | true |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | Undecided |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |